ABVC BioPharma Inc (ABVC)
1.07
-0.01
(-0.93%)
USD |
NASDAQ |
May 22, 14:19
ABVC BioPharma Shareholders Equity (Quarterly): 7.792M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.792M |
December 31, 2023 | 8.388M |
September 30, 2023 | 9.100M |
June 30, 2023 | -0.3793M |
March 31, 2023 | 1.670M |
December 31, 2022 | 3.099M |
September 30, 2022 | 5.919M |
June 30, 2022 | 9.334M |
March 31, 2022 | 7.427M |
December 31, 2021 | 8.844M |
September 30, 2021 | 8.594M |
June 30, 2021 | 1.440M |
March 31, 2021 | 2.572M |
December 31, 2020 | 3.438M |
September 30, 2020 | -0.5364M |
June 30, 2020 | -1.074M |
March 31, 2020 | -1.137M |
December 31, 2019 | -0.151M |
September 30, 2019 | 0.6659M |
June 30, 2019 | -3.320M |
March 31, 2019 | -5.762M |
December 31, 2018 | -5.749M |
September 30, 2018 | -2.449M |
June 30, 2018 | -2.238M |
March 31, 2018 | -1.933M |
Date | Value |
---|---|
December 31, 2017 | -1.757M |
September 30, 2017 | -1.393M |
June 30, 2017 | -1.048M |
March 31, 2017 | -0.9227M |
December 31, 2016 | -6.520M |
September 30, 2016 | -6.379M |
June 30, 2016 | 1.527M |
March 31, 2016 | 0.8707M |
December 31, 2015 | 0.0649M |
September 30, 2015 | 0.6334M |
June 30, 2015 | 0.0299M |
March 31, 2015 | 0.0287M |
December 31, 2014 | 0.0295M |
September 30, 2014 | 0.0314M |
June 30, 2014 | -1.880M |
March 31, 2014 | -1.880M |
December 31, 2013 | -1.880M |
September 30, 2013 | -1.880M |
June 30, 2013 | -1.880M |
March 31, 2013 | -1.841M |
December 31, 2012 | -1.801M |
September 30, 2012 | -1.644M |
June 30, 2012 | -1.450M |
March 31, 2012 | -1.384M |
December 31, 2011 | -1.349M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.320M
Minimum
Jun 2019
9.334M
Maximum
Jun 2022
3.584M
Average
2.835M
Median
Shareholders Equity (Quarterly) Benchmarks
NeuBase Therapeutics Inc | 9.137M |
Sutro Biopharma Inc | 98.02M |
Reviva Pharmaceuticals Holdings Inc | -1.346M |
Flora Growth Corp | 3.138M |
Journey Medical Corp | 12.95M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.46M |
Total Liabilities (Quarterly) | 6.973M |
Debt to Equity Ratio | 0.2186 |
Current Ratio | 0.2705 |
Net Debt Paydown Yield | 0.28% |